HomeBIIB • NASDAQ
Biogen Inc
$219.40
After Hours:
$219.40
(0.00%)0.00
Closed: Mar 18, 4:49:31 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$219.31
Day range
$217.53 - $220.56
Year range
$215.35 - $319.76
Market cap
31.89B USD
Avg Volume
1.32M
P/E ratio
27.51
Dividend yield
-
Primary exchange
NASDAQ
CDP Climate Change Score
B
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
2.39B-6.20%
Operating expense
1.31B-1.59%
Net income
249.70M-54.63%
Net profit margin
10.46-51.66%
Earnings per share
2.95-27.16%
EBITDA
601.20M-21.40%
Effective tax rate
14.64%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
1.05B-78.54%
Total assets
26.84B9.33%
Total liabilities
12.05B7.88%
Total equity
14.80B
Shares outstanding
145.36M
Price to book
2.15
Return on assets
4.19%
Return on capital
5.19%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
249.70M-54.63%
Cash from operations
12.50M107.14%
Cash from investing
-652.30M-362.30%
Cash from financing
-646.10M-8,631.08%
Net change in cash
-1.24B-383.03%
Free cash flow
-596.10M-84.17%
About
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Sweden, and Switzerland. Wikipedia
Founded
1978
Website
Employees
7,570
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu